Protein Expression of TLR2, TLR4, and TLR9 on Monocytes in TB, HIV, and TB/HIV.
Wegene TameneLiya WassieMahomed-Yunus MoosaMeseret AbebeAmha KebedeUlrich SackRawleigh HowePublished in: Journal of immunology research (2024)
Toll-like receptors (TLRs) have a critical role in recognizing pathogenic patterns and initiating immune responses against TB and HIV. Previously, studies described the gene expression of TLRs in patients with TB and HIV. Here, we demonstrated TLRs protein expressions and their association with clinical status and plasma markers in TB, HIV, and TB/HIV coinfection. The phenotyping of TLR2, TLR4, and TLR9 on CD14+ monocytes and their subsets were determined by multicolor flow cytometry. Host plasma biomarkers and microbial indices were measured using Luminex Multiplex assay and standard of care tools, respectively. TLR2 expression significantly enhanced in TB, slightly increased in HIV but slightly reduced in TB/HIV coinfection compared to apparently health controls (HC). On the other hand, TLR4 expression was significantly increased in TB, HIV, and TB/HIV compared to HC. Expression of TLR4 was equally enhanced on classical and intermediate monocytes while higher TLR2 expression on intermediate than classical monocytes. TLR4 had a positive correlation pattern with plasma biomarkers while TLR2 had an inverse correlation pattern. TLR4 is associated with disease severity while TLR2 is with the immune-competent status of patients. Our findings demonstrated that the pattern of TLR expression is disease as well as monocyte subset specific and distinct factors drive these differences.
Keyphrases
- toll like receptor
- antiretroviral therapy
- immune response
- inflammatory response
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- hiv aids
- hepatitis c virus
- mycobacterium tuberculosis
- men who have sex with men
- nuclear factor
- gene expression
- poor prognosis
- dendritic cells
- healthcare
- flow cytometry
- public health
- ejection fraction
- end stage renal disease
- high throughput
- small molecule
- peripheral blood
- dna methylation
- risk assessment
- quality improvement
- chronic kidney disease
- peritoneal dialysis